辉瑞以史上最大 ADC 并购案——430 亿美元收购 Seagen 后，艾伯维 101 亿、强生 20 亿、罗氏 10 亿，各家纷纷押注 ADC 赛道。今年依然热度不减，大冢制药 11 亿买入，罗氏再度加码 ADC 斥资 10 亿美元牵手 ...

Orum said recently that preclinical results with ORM-6151 suggest it should offer better tolerability than Pfizer’s Mylotarg (gemtuzumab ozogamicin), a CD33-targeting ADC that has been approved ...

This evolution in “savoir faire” has helped in managing ADC side effects ... FDA approval summary: mylotarg for treatment of patients with relapsed or refractory CD33‐positive acute myeloid ...

located in 49 states and containing approximately 47.2 million square feet of gross leasable area. The Company's common stock is listed on the New York Stock Exchange under the symbol "ADC".

No other corporate actions details are available.

Real time quote data is not available at this time. *Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green ...